Morphine

Generic Name
Morphine
Brand Names
Arymo, Avinza, Doloral, Duramorph, Embeda, Infumorph, Kadian, M-ediat, M-eslon, MSIR, Mitigo, Ms Contin, Statex
Drug Type
Small Molecule
Chemical Formula
C17H19NO3
CAS Number
57-27-2
Unique Ingredient Identifier
76I7G6D29C
Background

Morphine, the main alkaloid of opium, was first obtained from poppy seeds in 1805. It is a potent analgesic, though its use is limited due to tolerance, withdrawal, and the risk of abuse. Morphine is still routinely used today, though there are a number of semi-synthetic opioids of varying strength such as codeine, fentanyl, methadone, hydrocodone, hydromorp...

Indication

Morphine is used for the management of chronic, moderate to severe pain.

Opiods, including morphine, are effective for the short term management of pain. Patients taking opioids long term may need to be monitored for the development of physical dependence, addiction disorder, and drug abuse.

Associated Conditions
Chronic Pain, Severe Pain
Associated Therapies
-

Controlled-Release Oxycodone For Postoperative Analgesia After Video-Assisted Thoracic Surgery

First Posted Date
2008-05-21
Last Posted Date
2012-01-06
Lead Sponsor
University of Parma
Target Recruit Count
22
Registration Number
NCT00681174
Locations
🇮🇹

University Hospital / Azienda Ospedaliero-Universitaria, Parma, PR, Italy

Mechanisms of Hypoglycemia Associated Autonomic Failure

First Posted Date
2008-05-15
Last Posted Date
2021-01-14
Lead Sponsor
Albert Einstein College of Medicine
Target Recruit Count
116
Registration Number
NCT00678145
Locations
🇺🇸

Albert Einstein College of Medicine / General Clinical Research Center, Bronx, New York, United States

Clonidine and Morphine in Caudal Anesthesia

First Posted Date
2008-05-06
Last Posted Date
2010-03-19
Lead Sponsor
Federal University of Minas Gerais
Target Recruit Count
80
Registration Number
NCT00672347
Locations
🇧🇷

Santa Casa de Belo Horizonte Hospital, Belo Horizonte, Minas Gerais, Brazil

Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

First Posted Date
2008-04-17
Last Posted Date
2014-10-08
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
1
Registration Number
NCT00660348
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

A Randomized, Double-blind Comparison of Morphine and Sufentanil for Prehospital Traumatic Severe Acute Pain

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-04-11
Last Posted Date
2017-05-12
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
108
Registration Number
NCT00656773
Locations
🇫🇷

U H Toulouse Samu 31, Toulouse, France

Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion

Phase 2
Conditions
First Posted Date
2008-03-26
Last Posted Date
2009-07-08
Lead Sponsor
Oxford University Hospitals NHS Trust
Target Recruit Count
320
Registration Number
NCT00644319
Locations
🇬🇧

Oxford Radcliffe Hospital, Oxford, England, United Kingdom

Intra-Articular Morphine Versus Bupivacaine on Knee Motion in Patients With Osteoarthritis

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2008-03-14
Last Posted Date
2008-03-14
Lead Sponsor
Federal University of São Paulo
Target Recruit Count
30
Registration Number
NCT00636415
Locations
🇧🇷

Pain Setor of Federal University of Sao Paulo, Sao Paulo, SP, Brazil

Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2008-03-12
Last Posted Date
2016-05-09
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
36
Registration Number
NCT00634010
Locations
🇺🇸

LBJ General Hospital, Houston, Texas, United States

🇺🇸

The Michael E. DeBakey V.A. Medical Center, Houston, Texas, United States

🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Ketamine Improves Post-Thoracotomy Analgesia

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2008-02-29
Last Posted Date
2008-02-29
Lead Sponsor
Tel-Aviv Sourasky Medical Center
Target Recruit Count
44
Registration Number
NCT00625911
Locations
🇮🇱

Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

© Copyright 2024. All Rights Reserved by MedPath